Overview
Thesis provides personalized nootropic supplements to improve cognitive performance. It starts with an online quiz to tailor a starter kit of four blended nootropics, which customers sample over a month and can then work with wellness coaches to fine-tune the mix. It differentiates itself by combining structured personalization with ongoing coaching and using USA-sourced, rigorously tested ingredients. Its goal is to help health-conscious individuals—such as students, professionals, and athletes—optimize brain function safely and effectively through coach-supported nootropic plans.
Work here?Claim your company
Simplify's take
What believers are saying
- Thesis keeps expanding commercial hires and clinical-trial investment in 2026.
- HealthVetted's November 2026 review says ingredient evidence supports some focus benefits.
- Strong testimonial demand can convert into subscriptions before competitors replicate its bundling.
What critics are saying
- Clearheadlab's June 2026 review found no published placebo trials on finished Thesis blends.
- Premium pricing faces commoditization from cheaper caffeine-theanine and citicoline competitors.
- If personalization stays quiz-based, Thesis becomes a marketing layer over commodity supplements.
What makes Thesis unique
- Thesis personalizes nootropics through quiz-driven blend selection, not one-size-fits-all stacks.
- Thesis raised $13.7 million by May 2023, including Unilever Ventures backing.
- Thesis hired for partnerships in September 2026, signaling creator-led distribution focus.
Help us improve and share your feedback! Did you find this helpful?